TY - JOUR
T1 - Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus
AU - Readhead, Ben
AU - Haure-Mirande, Jean Vianney
AU - Funk, Cory C.
AU - Richards, Matthew A.
AU - Shannon, Paul
AU - Haroutunian, Vahram
AU - Sano, Mary
AU - Liang, Winnie S.
AU - Beckmann, Noam D.
AU - Price, Nathan D.
AU - Reiman, Eric M.
AU - Schadt, Eric E.
AU - Ehrlich, Michelle E.
AU - Gandy, Sam
AU - Dudley, Joel T.
N1 - Funding Information:
MSBB RNA-seq, WES, and proteomics data used for the evaluation of viral sequences in AD were generated from post-mortem brain tissue collected through the Mount Sinai VA Medical Center Brain Bank and were provided by Dr. Eric Schadt and Dr. Mary Sano from Mount Sinai School of Medicine (P50 AG005138). Proteomics data were also provided by Dr. Levey from Emory University. Construction of TReNA networks was supported by NIA grant U01AG046139 and NIH grant U54EB020406. The MAYO TCX RNAseq study data was led by Dr. Nilüfer Ertekin-Taner, Mayo Clinic, Jacksonville, FL as part of the multi-PI U01 AG046139 using samples from the following sources. (1) The Mayo Clinic Brain Bank. Data collection was supported through funding by NIA grants P50 AG016574, R01 AG032990, U01 AG046139, R01 AG018023, U01 AG006576, U01 AG006786, R01 AG025711, R01 AG017216, R01 AG003949, NINDS grant R01 NS080820, CurePSP Foundation, and support from Mayo Foundation. (2) Sun Health Research Institute Brain and Body Donation Program of Sun City, Arizona. The Brain and Body Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901, and 1001 to the Arizona Parkinson's Disease Consortium), and the Michael J. Fox Foundation for Parkinson's Research. The ROS/MAP RNAseq study data were provided by the Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago. Data collection was supported through funding by NIA grants P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, U01AG46152, the Illinois Department of Public Health, and the Translational Genomics Research Institute. S.G. and M.E.E. acknowledge the support of U01 AG046170 from the NIA. B.R., S.G., M.E.E., and J.T.D. acknowledge the support of 1R56AG058469 from the NIA. Philanthropic financial support was provided by Katherine Gehl. The computational resources and staff expertise provided by the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai also contributed to the performance of this research.
Funding Information:
MSBB RNA-seq, WES, and proteomics data used for the evaluation of viral sequences in AD were generated from post-mortem brain tissue collected through the Mount Sinai VA Medical Center Brain Bank and were provided by Dr. Eric Schadt and Dr. Mary Sano from Mount Sinai School of Medicine (P50 AG005138). Proteomics data were also provided by Dr. Levey from Emory University. Construction of TReNA networks was supported by NIA grant U01AG046139 and NIH grant U54EB020406 . The MAYO TCX RNAseq study data was led by Dr. Nilüfer Ertekin-Taner, Mayo Clinic, Jacksonville, FL as part of the multi-PI U01 AG046139 using samples from the following sources. (1) The Mayo Clinic Brain Bank. Data collection was supported through funding by NIA grants P50 AG016574 , R01 AG032990 , U01 AG046139 , R01 AG018023 , U01 AG006576 , U01 AG006786 , R01 AG025711 , R01 AG017216 , R01 AG003949 , NINDS grant R01 NS080820 , CurePSP Foundation , and support from Mayo Foundation . (2) Sun Health Research Institute Brain and Body Donation Program of Sun City, Arizona. The Brain and Body Donation Program is supported by the National Institute of Neurological Disorders and Stroke ( U24 NS072026 National Brain and Tissue Resource for Parkinson’s Disease and Related Disorders), the National Institute on Aging ( P30 AG19610 Arizona Alzheimer’s Disease Core Center), the Arizona Department of Health Services (contract 211002 , Arizona Alzheimer’s Research Center), the Arizona Biomedical Research Commission (contracts 4001 , 0011 , 05-901 , and 1001 to the Arizona Parkinson’s Disease Consortium), and the Michael J. Fox Foundation for Parkinson's Research . The ROS/MAP RNAseq study data were provided by the Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago. Data collection was supported through funding by NIA grants P30AG10161 , R01AG15819 , R01AG17917 , R01AG30146 , R01AG36836 , U01AG32984 , U01AG46152 , the Illinois Department of Public Health , and the Translational Genomics Research Institute . S.G. and M.E.E. acknowledge the support of U01 AG046170 from the NIA . B.R., S.G., M.E.E., and J.T.D. acknowledge the support of 1R56AG058469 from the NIA . Philanthropic financial support was provided by Katherine Gehl . The computational resources and staff expertise provided by the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai also contributed to the performance of this research.
Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2018/7/11
Y1 - 2018/7/11
N2 - Investigators have long suspected that pathogenic microbes might contribute to the onset and progression of Alzheimer's disease (AD) although definitive evidence has not been presented. Whether such findings represent a causal contribution, or reflect opportunistic passengers of neurodegeneration, is also difficult to resolve. We constructed multiscale networks of the late-onset AD-associated virome, integrating genomic, transcriptomic, proteomic, and histopathological data across four brain regions from human post-mortem tissue. We observed increased human herpesvirus 6A (HHV-6A) and human herpesvirus 7 (HHV-7) from subjects with AD compared with controls. These results were replicated in two additional, independent and geographically dispersed cohorts. We observed regulatory relationships linking viral abundance and modulators of APP metabolism, including induction of APBB2, APPBP2, BIN1, BACE1, CLU, PICALM, and PSEN1 by HHV-6A. This study elucidates networks linking molecular, clinical, and neuropathological features with viral activity and is consistent with viral activity constituting a general feature of AD. Readhead et al. construct multiscale networks of the late-onset Alzheimer's disease (AD)-associated virome and observe pathogenic regulation of molecular, clinical, and neuropathological networks by several common viruses, particularly human herpesvirus 6A and human herpesvirus 7.
AB - Investigators have long suspected that pathogenic microbes might contribute to the onset and progression of Alzheimer's disease (AD) although definitive evidence has not been presented. Whether such findings represent a causal contribution, or reflect opportunistic passengers of neurodegeneration, is also difficult to resolve. We constructed multiscale networks of the late-onset AD-associated virome, integrating genomic, transcriptomic, proteomic, and histopathological data across four brain regions from human post-mortem tissue. We observed increased human herpesvirus 6A (HHV-6A) and human herpesvirus 7 (HHV-7) from subjects with AD compared with controls. These results were replicated in two additional, independent and geographically dispersed cohorts. We observed regulatory relationships linking viral abundance and modulators of APP metabolism, including induction of APBB2, APPBP2, BIN1, BACE1, CLU, PICALM, and PSEN1 by HHV-6A. This study elucidates networks linking molecular, clinical, and neuropathological features with viral activity and is consistent with viral activity constituting a general feature of AD. Readhead et al. construct multiscale networks of the late-onset Alzheimer's disease (AD)-associated virome and observe pathogenic regulation of molecular, clinical, and neuropathological networks by several common viruses, particularly human herpesvirus 6A and human herpesvirus 7.
KW - Alzheimer's disease
KW - HHV-6A
KW - HHV-6B
KW - HHV-7
KW - Roseolovirus
KW - human herpesvirus
KW - integrative genomics
KW - multiscale networks
KW - network biology
KW - systems biology
UR - http://www.scopus.com/inward/record.url?scp=85048428753&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048428753&partnerID=8YFLogxK
U2 - 10.1016/j.neuron.2018.05.023
DO - 10.1016/j.neuron.2018.05.023
M3 - Article
C2 - 29937276
AN - SCOPUS:85048428753
SN - 0896-6273
VL - 99
SP - 64-82.e7
JO - Neuron
JF - Neuron
IS - 1
ER -